Lineage Cell Therapeutics In shares owned by Commonwealth Equity Services
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Commonwealth Equity Services
from 13F filings
Historical chart of Commonwealth Equity Services investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Commonwealth Equity Services
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $171k | 101k | 1.69 |
| 2025-06-30 | $56k | 62k | 0.91 |
| 2025-03-31 | $27k | 59k | 0.46 |
| 2024-12-31 | $30k | 59k | 0.51 |
| 2024-09-30 | $44k | 48k | 0.91 |
| 2024-06-30 | $48k | 48k | 1.01 |
| 2024-03-31 | $71k | 48k | 1.49 |
| 2023-12-31 | $52k | 48k | 1.09 |
| 2023-09-30 | $64k | 55k | 1.17 |
| 2023-06-30 | $73k | 52k | 1.42 |
| 2023-03-31 | $72k | 49k | 1.48 |
| 2022-12-31 | $57k | 49k | 1.16 |
| 2022-09-30 | $48k | 43k | 1.12 |
| 2022-06-30 | $71k | 46k | 1.56 |
| 2022-03-31 | $70k | 46k | 1.54 |
| 2021-12-31 | $94k | 39k | 2.43 |
| 2021-09-30 | $110k | 44k | 2.50 |
| 2021-06-30 | $154k | 54k | 2.83 |
| 2021-03-31 | $113k | 48k | 2.34 |
| 2020-12-31 | $158k | 90k | 1.76 |
| 2020-09-30 | $85k | 91k | 0.93 |
| 2020-06-30 | $74k | 85k | 0.87 |
| 2020-03-31 | $61k | 75k | 0.82 |
| 2019-12-31 | $59k | 67k | 0.88 |
| 2019-09-30 | $112k | 114k | 0.98 |
More positions owned by Commonwealth Equity Services
View all positions for Commonwealth Equity Services